Citadel Advisors’s Clene CLNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,835
Closed -$111K 14587
2024
Q4
$111K Buy
+20,835
New +$105K ﹤0.01% 11332
2024
Q3
Sell
-1,929
Closed -$13.7K 14323
2024
Q2
$13.7K Sell
1,929
-9,833
-84% -$73.6K ﹤0.01% 12926
2024
Q1
$100K Sell
11,762
-2,305
-16% -$19.9K ﹤0.01% 11358
2023
Q4
$83.4K Buy
14,067
+818
+6% +$7.13K ﹤0.01% 11162
2023
Q3
$131K Sell
13,249
-79,419
-86% -$1.1M ﹤0.01% 10545
2023
Q2
$1.63M Buy
+92,668
New +$1.81M ﹤0.01% 5532
2023
Q1
Sell
-173
Closed -$4.49K 14801
2022
Q4
$3.45K Sell
173
-1,650
-91% -$38.3K ﹤0.01% 14211
2022
Q3
$102K Sell
1,823
-1,440
-44% -$95.4K ﹤0.01% 11075
2022
Q2
$164K Buy
+3,263
New +$182K ﹤0.01% 10889
2021
Q4
Sell
-1,030
Closed -$110K 13870
2021
Q3
$140K Buy
+1,030
New +$176K ﹤0.01% 12456
2021
Q2
Sell
-2,308
Closed -$590K 13724
2021
Q1
$590K Buy
+2,308
New +$506K ﹤0.01% 9322

Other funds holding CLNN

Citadel Advisors's CLNN Position: Q1 2025 in Review

Citadel Advisors sold out of Clene (CLNN) in Q1 2025, closing a stake of 20,835 shares — an estimated $111K sold.

Citadel Advisors first reported a position in CLNN in Q1 2021 and held it in 11 quarters. The position peaked at $1.63M in Q2 2023. 24 funds tracked by Wall St. Rank hold CLNN as of Q1 2025.

  • Citadel Advisors reported no remaining Clene position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 20,835 Clene shares in Q1 2025, an estimated $111K.
  • Citadel Advisors first reported a position in Clene in Q1 2021 and held it in 11 quarters.
  • Citadel Advisors's Clene position peaked at $1.63M in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Clene as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.